TUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque psoriasis of the scalp and body in adult and pediatric patients 12 years of age and older.
(The Center Square) – The U.S. Department of Health and Human Services has removed mRNA COVID-19 vaccines from children and pregnant women’s recommended immunization schedules, reversing the Centers for Disease Control and Prevention’s blanket recommendation that every American over the age of six months receive a booster shot annually.
"I want to help make sure more people understand how overlooked brain tumors still are.”
Scientists found that climate change in the Middle East and North Africa is making breast, ovarian, uterine, and cervical cancer more common and more deadly.
The US will no longer recommend Covid-19 vaccines for children and healthy pregnant women, Health Secretary Robert F. Kennedy Jr. announced Tuesday, calling it a "common sense" decision grounded in sound science.
The findings show that the percentage of mothers reporting "excellent" mental health plummeted from 38% in 2016 to 26% in 2023.
